CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −89 | $6.63 | $590 | 26,827 |
| 2024-08-16 | Hyllengren Eric J EVP, CFO | Sale | −1,041 | $6.63 | $7K | 24,785 |
| 2024-08-16 | Hyllengren Eric J EVP, CFO | Sale | −29 | $6.63 | $192 | 24,756 |
| 2024-08-16 | Henrich Jill EVP, Global Head RA & Quality | Sale | −831 | $6.63 | $6K | 20,510 |
| 2024-08-16 | Henrich Jill EVP, Global Head RA & Quality | Sale | −132 | $6.63 | $875 | 20,378 |
| 2024-08-12 | Touchon Pascal President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −9,000 | 0 | ||
| 2024-08-12 | Touchon Pascal President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −9,680 | 0 | ||
| 2024-08-12 | Touchon Pascal President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −7,075 | 0 | ||
| 2024-05-16 | Touchon Pascal President and CEO | Sale | −81,506 | $0.62 | $50K | 1,829,146 |
| 2024-05-16 | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | Sale | −42,899 | $0.62 | $26K | 898,498 |
| 2024-05-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −32,401 | $0.62 | $20K | 695,120 |
| 2024-05-16 | Hyllengren Eric J EVP, CFO | Sale | −28,648 | $0.62 | $18K | 645,671 |
| 2024-05-16 | Henrich Jill EVP, Global Head RA & Quality | Sale | −25,750 | $0.62 | $16K | 529,251 |
| 2024-03-31 | Fust Matthew K Director | Grant or award | +150,000 | 259,000 | ||
| 2024-03-31 | HEIDEN WILLIAM K Director | Grant or award | +150,000 | 359,000 | ||
| 2024-03-31 | Roncarolo Maria Grazia Director | Grant or award | +150,000 | 238,500 | ||
| 2024-03-31 | Gallagher Carol Giltner Director | Grant or award | +150,000 | 629,608 | ||
| 2024-03-31 | MALLIK AMEET Director | Grant or award | +150,000 | 227,500 | ||
| 2024-03-04 | Touchon Pascal President and CEO | Sale | −24,844 | $0.72 | $18K | 1,910,652 |
| 2024-03-04 | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | Sale | −10,746 | $0.72 | $8K | 941,397 |
Page 5 of 17 · 334 trades